Vaccination, especially booster doses, reduces the risk of long COVID by up to 29%, highlighting its critical role in preventing lingering Omicron-era complications.
Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments – Biotech Investments
EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments 18.04.2024 / 13:27 CET/CEST The